ceocfomeetthepress.com ceocfomeetthepress.com

ceocfomeetthepress.com

Inhale Therapies Respiratory Diseases, Pulmatrix, Inc. (NASDAQ: PULM)

Pulmonary Drug Delivery, Dr. Robert Clarke, Ph.D., With Clinical Data Showing Achievement of Pharmacokinetic Bio Equivalence for their Bronchodilator for use in COPD in the European Market and Qualified Infectious Disease Product Status from the FDA for their Inhaled Antifungal to treat Cystic Fibrosis, Pulmatrix is positioned for Continued Growth in 2017, CEO Interviews 2016, Drug Delivery Companies

http://www.ceocfomeetthepress.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR CEOCFOMEETTHEPRESS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 13 reviews
5 star
6
4 star
4
3 star
2
2 star
0
1 star
1

Hey there! Start your review of ceocfomeetthepress.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

2.4 seconds

FAVICON PREVIEW

  • ceocfomeetthepress.com

    16x16

  • ceocfomeetthepress.com

    32x32

  • ceocfomeetthepress.com

    64x64

  • ceocfomeetthepress.com

    128x128

  • ceocfomeetthepress.com

    160x160

  • ceocfomeetthepress.com

    192x192

CONTACTS AT CEOCFOMEETTHEPRESS.COM

PARTIES TO REMEMBER

WALTER RIVERS

PO B●●●●6186

PALM●●●●RBOR , FL, 34684

US

1.57●●●●1989
WA●●●●●●●●●●●@YAHOO.COM

View this contact

PARTIES TO REMEMBER

WALTER RIVERS

PO B●●●●6186

PALM●●●●RBOR , FL, 34684

US

1.57●●●●1989
WA●●●●●●●●●●●@YAHOO.COM

View this contact

PARTIES TO REMEMBER

WALTER RIVERS

PO B●●●●6186

PALM●●●●RBOR , FL, 34684

US

1.57●●●●1989
WA●●●●●●●●●●●@YAHOO.COM

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2010 March 28
UPDATED
2014 February 27
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 14

    YEARS

  • 1

    MONTHS

  • 23

    DAYS

NAME SERVERS

1
dns1.name-services.com
2
dns2.name-services.com
3
dns3.name-services.com
4
dns4.name-services.com
5
dns5.name-services.com

REGISTRAR

ENOM, INC.

ENOM, INC.

WHOIS : whois.enom.com

REFERRED : http://www.enom.com

CONTENT

SCORE

6.2

PAGE TITLE
Inhale Therapies Respiratory Diseases, Pulmatrix, Inc. (NASDAQ: PULM) | ceocfomeetthepress.com Reviews
<META>
DESCRIPTION
Pulmonary Drug Delivery, Dr. Robert Clarke, Ph.D., With Clinical Data Showing Achievement of Pharmacokinetic Bio Equivalence for their Bronchodilator for use in COPD in the European Market and Qualified Infectious Disease Product Status from the FDA for their Inhaled Antifungal to treat Cystic Fibrosis, Pulmatrix is positioned for Continued Growth in 2017, CEO Interviews 2016, Drug Delivery Companies
<META>
KEYWORDS
1 iSPERSE
2 dry powder technology
3 Personally
4 our particles can easily get into the patients’ airways
5 provide efficient drug delivery to the lungs
6 allow us to deliver higher doses than traditional technologies
7 Pulmatrix
8 Inc. Press Releases
9 News
10 Drug Delivery Stock
CONTENT
Page content here
KEYWORDS ON
PAGE
ceocfo mobile,ceocfo services,pulmatrix,ceocfo,members login,eocfo magazine,dr robert clarke,interview conducted by,dr clarke,mobile download,investors,disclaimers
SERVER
nginx
POWERED BY
PleskLin
CONTENT-TYPE
iso-8859-1
GOOGLE PREVIEW

Inhale Therapies Respiratory Diseases, Pulmatrix, Inc. (NASDAQ: PULM) | ceocfomeetthepress.com Reviews

https://ceocfomeetthepress.com

Pulmonary Drug Delivery, Dr. Robert Clarke, Ph.D., With Clinical Data Showing Achievement of Pharmacokinetic Bio Equivalence for their Bronchodilator for use in COPD in the European Market and Qualified Infectious Disease Product Status from the FDA for their Inhaled Antifungal to treat Cystic Fibrosis, Pulmatrix is positioned for Continued Growth in 2017, CEO Interviews 2016, Drug Delivery Companies

LINKS TO THIS WEBSITE

ceocfointerviews.com ceocfointerviews.com

INDEX, CEO-CFO-Analyst Interviews, Interview Questions, Stocks, Financial and Business News, Investor Information!

http://www.ceocfointerviews.com/CoverIndex.htm

Weekly Print Online Publication Featuring In-Depth Interviews with many of Today's Top Corporate Executives. August 15, 2016 Issue. 60 Degrees Pharmaceuticals, LLC. Therapeutics and Travel Medicine for Tropical Diseases such as Dengue Fever and Malaria. Software Defined All-Flash Array for Managing Flash Memory in Data Centers Offering High Performance with 600K IOPS for 4KB Random Writes. Proprietary Nonlinear Optimization and Breakthrough Control Technologies for Dynamic Systems. Applied BioMath, LLC.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

1

SOCIAL ENGAGEMENT



OTHER SITES

ceocfolatestnews.com ceocfolatestnews.com

Medical Cannabinoid, GB Sciences, Inc.

Growblox Life Sciences, LLC (wholly-owned subsidiary). GB Sciences, Inc. (OTCQB: GBLX) (parent company). 19, 2018 Issue. Focused on Plant-based Medicine, GB Sciences, Inc. has developed one of the finest Cultivation Facilities in the US and a suite of Cannabinoid-based Compounds showing promise in the Treatment of Parkinson s Disease and Neuropathic Pain. Growblox Life Sciences, LLC (wholly-owned subsidiary). GB Sciences, Inc. (OTCQB: GBLX) (parent company). Bud Wayne, Editorial Executive. In closing, wh...

ceocfolibrary.com ceocfolibrary.com

IT Support, Asierus Carefree Technology

26, 2018 Issue. Q&A with Jeremy Hale Simmons, Founder and CEO of Asierus Carefree Technology, An all-in-one IT, Business Management and Marketing Company. Founder and Chief Executive Officer. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published February 26, 2018. CEOCFO: Mr. Simmons, what was the vision when you started Asierus Carefree Technology , back in 2005? I also was among the first, if not the,. CEOCFO: What is the offering today? I am in Ballard, Utah. Where the heck is Ballard, Utah? They woul...

ceocfolist.com ceocfolist.com

The CEO & CFO List

The CEO & CFO List. With clients and partners. What Our Clients Say About Us. Caliber’s ability to identify and connect with influential media and contacts has allowed us to stand out even our investors took notice. We view Caliber as an extension of our team, and an extremely valuable partner. Global Marketing & Communications. Marketing & Communications. Caliber’s insight, level of service, and ability to execute a targeted custom event reaching Fortune 500 companies helped us successfully showcase our...

ceocfomarketguide.com ceocfomarketguide.com

AMD Monitoring Program, Notal Vision, Inc.

Notal Vision, Inc. 19, 2018 Issue. Q&A with Quinton Oswald, CEO and Jim Long, CFO, Notal Vision, Inc. providing the first Cloud Based Platform for Patient Administered at Home Vision Monitoring and Diagnosis of Dry AMD and Retinal Disease. Notal Vision, Inc. Interview with Quinton Oswald, Chief Executive Officer and. Jim Long, Chief Financial Officer conducted by:. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published February 19, 2018. What is the technology and science to do this remotely? CEOCFO: What...

ceocfomarketwatch.com ceocfomarketwatch.com

Private High schools, Fusion Education Group

12, 2018 Issue. Q&A with Peter G. Ruppert, President and CEO of Fusion Education Group and their chain of 43 Fusion Academy flagship private schools providing Customized, One-to-One Education enabling Greater Student Success. Peter G. Ruppert. President and Chief Executive Officer. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published February 12, 2018. CEOCFO: Mr. Ruppert, what is the concept behind Fusion Education Group? CEOCFO: How do you go about recognizing what is best for any given child? CEOCFO:...

ceocfomeetthepress.com ceocfomeetthepress.com

Inhale Therapies Respiratory Diseases, Pulmatrix, Inc. (NASDAQ: PULM)

July 31, 2017 Issue. With Clinical Data Showing Achievement of Pharmacokinetic Bio Equivalence for their Bronchodilator for use in COPD in the European Market and Qualified Infectious Disease Product Status from the FDA for their Inhaled Antifungal to treat Cystic Fibrosis, Pulmatrix is positioned for Continued Growth in 2017. Http:/ pulmatrix.com/index.php. Bud Wayne, Editorial Executive, CEOCFO Magazine, Published July 31, 2017. How does that differ from the traditional way of treating these diseases?

ceocfomobile.com ceocfomobile.com

CEOCFO mobile for Mobile Phones and eBook Readers

19, 2018 Issue. Adobe PDF Reader for Android/Kindle, iPad/iPhone. Http:/ www.adobe.com/products/reader-mobile.html. Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF). A Health Canada Licensed Producer of Medical Cannabis allowing them to Cultivate, Grow and Sell Medical Marijuana and Oils to Patients Across the Country. Print Version - PDF. Print Version - PDF. Print Version - PDF. Print Version - PDF. An all-in-one IT, Business Management and Marketing Company. Print Version - PDF. Leading pro...

ceocfonews.com ceocfonews.com

Data Quality and Direct Mail Software, AccuZIP, Inc., Technology Companies

7, 2014 Issue. The Most Powerful Name In Corporate News and Information. Data Quality and Mailing Software. About AccuZIP, Inc. AccuZIP Inc. is a leading provider of data quality software. Data is the anchor of any business. It is the base of every business decision, customer relationship, and business investment. Mr Belmonte resides on the central coast of California with his wife and three children. He enjoys doing pretty much anything that includes time with his family. Bettering his local com...AccuZ...

ceocfonewsbiz.com ceocfonewsbiz.com

Automotive Training, ATech Training, Inc.

ATech Training, Inc. 26, 2018 Issue. Q&A with Laura Lyons, President and CEO of ATech Training, Inc. a Global provider of Training Devices, Courseware for Instructors and Management for the Automotive Classroom using NATEF Standards and Guidelines. President and Chief Executive Officer. ATech Training, Inc. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published February 26, 2018. Ms Lyons, what is the focus at ATech Training Inc. today? How do you put that all together? CEOCFO: Are there many companies or...

ceocfonewsline.com ceocfonewsline.com

Cannabinoid-based Therapeutics, Nemus Bioscience

26, 2018 Issue. Nemus Bioscience is developing Bio-engineered Medicines using Cannabinoid Molecules in a Pro-drug of THC to offer a Revolutionary Treatment for Glaucoma Patients with a Dual Benefit of Lowering Intraocular Pressure and Providing Neuroprotection. Dr Brian Murphy, MD, MPH, MBA. Chief Executive Officer; Chief Medical Officer, Director. Http:/ www.nemusbioscience.com/home/default.aspx. Bud Wayne, Editorial Executive, CEOCFO Magazine, Published February 26, 2018. Cannabinoid-based therapies ar...

ceocfonotes.com ceocfonotes.com

Private High schools, Fusion Education Group

12, 2018 Issue. Q&A with Peter G. Ruppert, President and CEO of Fusion Education Group and their chain of 43 Fusion Academy flagship private schools providing Customized, One-to-One Education enabling Greater Student Success. Peter G. Ruppert. President and Chief Executive Officer. Lynn Fosse, Senior Editor, CEOCFO Magazine, Published February 12, 2018. CEOCFO: Mr. Ruppert, what is the concept behind Fusion Education Group? CEOCFO: How do you go about recognizing what is best for any given child? CEOCFO:...